Executive Summary
AI
- Vincent presents a Cell Host & Microbe snippet on the evolution of antibody cross-reactivity to H5N1 neuraminidase from an N2-specific germline, first author Huibin Luv, corresponding authors Chris Mock and Nicholas Wu of the University of Illinois and the Chinese University of Hong Kong.5:43
- The group screened plasma from 245 healthy people in Hong Kong collected between January and March 2020 and found anti-neuraminidase antibodies against H1N1, H3N2 and even H5N1, higher in younger age groups, which they attribute to imprinting by H1N1 infection.9:11
- A phage display library yielded a single public clone, HB420, and its structure with an H3N2 neuraminidase shows the CDR H3 inserting into the enzyme's active site and mimicking sialic acid, while an N-linked glycosylation site acquired at residue 245 since 2016 blocks binding to recent human H3N2 strains.17:18
- In mice, HB420 gave complete protection against H3N2 with 100% survival and minimal weight loss, 40% survival and a two-log lung titre reduction against a virus bearing the N1 of H5N1, and a LALA variant lost that protection, pointing to Fc effector functions rather than neutralisation.29:03
- Steph then covers a Nature paper from May 2025 by Tamami Yoshida and Andrew Wang at Yale showing that the subfornical organ holds gut-derived CD4 T cells in mice and in human autopsy tissue, and that interferon gamma from those cells, along with CXCR6, is needed for normal feeding behaviour in a stress test.33:30
Key Quote
“So the interesting part of this paper is they solve the structure of this antibody, HB420, to an H3N2NA, right?”
— Vincent Racaniello17:18
Key Quote
“So they're painting this picture that in the gut, these T-cells can migrate to the brain.”
— Steph Lange1:03:55
Key Quote
“So are you convinced that there are a specific subset of FTC cells in the parenchyma?”
— Vincent Racaniello1:25:40